vs

Side-by-side financial comparison of BOX INC (BOX) and NEOGEN CORP (NEOG). Click either name above to swap in a different company.

BOX INC is the larger business by last-quarter revenue ($301.1M vs $224.7M, roughly 1.3× NEOGEN CORP). BOX INC runs the higher net margin — 4.0% vs -7.1%, a 11.1% gap on every dollar of revenue. On growth, BOX INC posted the faster year-over-year revenue change (9.1% vs -2.8%). BOX INC produced more free cash flow last quarter ($71.3M vs $7.8M). Over the past eight quarters, BOX INC's revenue compounded faster (7.0% CAGR vs -0.9%).

Box, Inc. is an American public company based in Redwood City, California. It develops and markets cloud-based content management, collaboration, and file sharing tools for businesses. Box was founded in 2005 by Aaron Levie and Dylan Smith. Initially, it focused on consumers, but around 2009 and 2010 Box pivoted to focus on business users. The company raised about $500 million over numerous funding rounds before going public in 2015. Its software allows users to store and manage files in an o...

Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abuse...

BOX vs NEOG — Head-to-Head

Bigger by revenue
BOX
BOX
1.3× larger
BOX
$301.1M
$224.7M
NEOG
Growing faster (revenue YoY)
BOX
BOX
+12.0% gap
BOX
9.1%
-2.8%
NEOG
Higher net margin
BOX
BOX
11.1% more per $
BOX
4.0%
-7.1%
NEOG
More free cash flow
BOX
BOX
$63.5M more FCF
BOX
$71.3M
$7.8M
NEOG
Faster 2-yr revenue CAGR
BOX
BOX
Annualised
BOX
7.0%
-0.9%
NEOG

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
BOX
BOX
NEOG
NEOG
Revenue
$301.1M
$224.7M
Net Profit
$12.1M
$-15.9M
Gross Margin
79.6%
47.5%
Operating Margin
8.3%
-2.4%
Net Margin
4.0%
-7.1%
Revenue YoY
9.1%
-2.8%
Net Profit YoY
-6.4%
96.5%
EPS (diluted)
$0.05
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BOX
BOX
NEOG
NEOG
Q4 25
$301.1M
$224.7M
Q3 25
$294.0M
$209.2M
Q2 25
$276.3M
$225.4M
Q1 25
$279.5M
$221.0M
Q4 24
$275.9M
$231.3M
Q3 24
$270.0M
$217.0M
Q2 24
$264.7M
$236.8M
Q1 24
$262.9M
$228.8M
Net Profit
BOX
BOX
NEOG
NEOG
Q4 25
$12.1M
$-15.9M
Q3 25
$13.4M
$36.3M
Q2 25
$8.2M
$-612.3M
Q1 25
$194.0M
$-10.9M
Q4 24
$12.9M
$-456.3M
Q3 24
$20.5M
$-12.6M
Q2 24
$17.2M
$-5.4M
Q1 24
$99.2M
$-2.0M
Gross Margin
BOX
BOX
NEOG
NEOG
Q4 25
79.6%
47.5%
Q3 25
79.1%
45.4%
Q2 25
78.0%
41.2%
Q1 25
79.0%
49.9%
Q4 24
79.9%
49.0%
Q3 24
79.4%
48.4%
Q2 24
78.0%
47.9%
Q1 24
76.1%
51.1%
Operating Margin
BOX
BOX
NEOG
NEOG
Q4 25
8.3%
-2.4%
Q3 25
7.0%
-7.7%
Q2 25
2.3%
-271.1%
Q1 25
6.4%
2.4%
Q4 24
8.5%
-197.8%
Q3 24
7.5%
1.0%
Q2 24
6.8%
5.5%
Q1 24
8.1%
5.3%
Net Margin
BOX
BOX
NEOG
NEOG
Q4 25
4.0%
-7.1%
Q3 25
4.6%
17.4%
Q2 25
3.0%
-271.6%
Q1 25
69.4%
-4.9%
Q4 24
4.7%
-197.3%
Q3 24
7.6%
-5.8%
Q2 24
6.5%
-2.3%
Q1 24
37.7%
-0.9%
EPS (diluted)
BOX
BOX
NEOG
NEOG
Q4 25
$0.05
$-0.07
Q3 25
$0.05
$0.17
Q2 25
$0.02
$-2.82
Q1 25
$1.13
$-0.05
Q4 24
$0.05
$-2.10
Q3 24
$0.10
$-0.06
Q2 24
$0.08
$-0.02
Q1 24
$0.57
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BOX
BOX
NEOG
NEOG
Cash + ST InvestmentsLiquidity on hand
$729.6M
$145.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-286.6M
$2.1B
Total Assets
$1.6B
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BOX
BOX
NEOG
NEOG
Q4 25
$729.6M
$145.3M
Q3 25
$757.9M
$138.9M
Q2 25
$790.4M
$129.0M
Q1 25
$722.8M
$127.7M
Q4 24
$697.9M
$140.2M
Q3 24
$482.2M
$120.5M
Q2 24
$566.1M
$170.9M
Q1 24
$480.7M
$168.4M
Stockholders' Equity
BOX
BOX
NEOG
NEOG
Q4 25
$-286.6M
$2.1B
Q3 25
$-269.4M
$2.1B
Q2 25
$-280.1M
$2.1B
Q1 25
$-297.0M
$2.7B
Q4 24
$-479.9M
$2.7B
Q3 24
$-439.4M
$3.1B
Q2 24
$-397.9M
$3.1B
Q1 24
$-431.1M
$3.1B
Total Assets
BOX
BOX
NEOG
NEOG
Q4 25
$1.6B
$3.4B
Q3 25
$1.6B
$3.4B
Q2 25
$1.6B
$3.4B
Q1 25
$1.7B
$4.0B
Q4 24
$1.4B
$4.1B
Q3 24
$1.1B
$4.5B
Q2 24
$1.2B
$4.5B
Q1 24
$1.2B
$4.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BOX
BOX
NEOG
NEOG
Operating Cash FlowLast quarter
$73.0M
$19.4M
Free Cash FlowOCF − Capex
$71.3M
$7.8M
FCF MarginFCF / Revenue
23.7%
3.5%
Capex IntensityCapex / Revenue
0.6%
5.2%
Cash ConversionOCF / Net Profit
6.05×
TTM Free Cash FlowTrailing 4 quarters
$343.5M
$-18.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BOX
BOX
NEOG
NEOG
Q4 25
$73.0M
$19.4M
Q3 25
$46.0M
$10.9M
Q2 25
$127.1M
$16.4M
Q1 25
$102.2M
$19.5M
Q4 24
$62.6M
$40.3M
Q3 24
$36.3M
$-17.9M
Q2 24
$131.2M
$26.7M
Q1 24
$89.3M
$-30.2M
Free Cash Flow
BOX
BOX
NEOG
NEOG
Q4 25
$71.3M
$7.8M
Q3 25
$43.9M
$-13.1M
Q2 25
$126.7M
$349.0K
Q1 25
$101.5M
$-13.4M
Q4 24
$62.3M
$23.1M
Q3 24
$35.9M
$-56.3M
Q2 24
$129.9M
$2.5M
Q1 24
$89.1M
$-62.3M
FCF Margin
BOX
BOX
NEOG
NEOG
Q4 25
23.7%
3.5%
Q3 25
14.9%
-6.3%
Q2 25
45.9%
0.2%
Q1 25
36.3%
-6.1%
Q4 24
22.6%
10.0%
Q3 24
13.3%
-26.0%
Q2 24
49.1%
1.1%
Q1 24
33.9%
-27.2%
Capex Intensity
BOX
BOX
NEOG
NEOG
Q4 25
0.6%
5.2%
Q3 25
0.7%
11.5%
Q2 25
0.1%
7.1%
Q1 25
0.2%
14.9%
Q4 24
0.1%
7.4%
Q3 24
0.1%
17.7%
Q2 24
0.5%
10.2%
Q1 24
0.1%
14.0%
Cash Conversion
BOX
BOX
NEOG
NEOG
Q4 25
6.05×
Q3 25
3.42×
0.30×
Q2 25
15.51×
Q1 25
0.53×
Q4 24
4.85×
Q3 24
1.77×
Q2 24
7.62×
Q1 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BOX
BOX

Segment breakdown not available.

NEOG
NEOG

Other$109.2M49%
Bacterial And General Sanitation$44.9M20%
Services$25.7M11%
Natural Toxins And Allergens$20.4M9%
Animal Care$8.9M4%
Genomics Services$6.3M3%
Biosecurity Products$4.6M2%
Life Sciences$1.4M1%

Related Comparisons